Geron Corp
GERNHealthcare|Biotechnology|USA
$1.50
-0.07 (-4.15%)
Tangible Book
$0.36
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (124)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | 2026-02-18 | SELL | 9,855 | $1.94 | $19.1K |
| LAWLIS V BRYAN | Director | 2025-05-09 | BUY | 13,300 | $1.18 | $15.7K |
| Samuels Scott Alan | EVP, Chief Legal Officer | 2025-02-27 | BUY | 15,000 | $1.61 | $24.2K |
| SCARLETT JOHN A | Chairman, President and CEO | 2025-02-27 | BUY | 12,500 | $1.77 | $22.1K |
| Ziegler James | EVP, Chief Commercial Officer | 2025-02-27 | BUY | 100,000 | $1.6 | $160K |
| GRETHLEIN ANDREW J | EVP, COO | 2024-07-08 | SELL | 674,348 | $4.56 | $3075K |
| Feller Faye | EVP, Chief Medical Officer | 2024-06-10 | SELL | 287,900 | $4.63 | $1333K |
| Kapur Anil | EVP, Corp Strategy & CCO | 2024-06-10 | SELL | 421,875 | $4.65 | $1961.7K |
| SCARLETT JOHN A | Chairman, President and CEO | 2024-06-04 | SELL | 600,000 | $4 | $2400K |
| O'Farrell Elizabeth G. | Director | 2023-08-24 | BUY | 13,186 | $2.28 | $30.1K |
| LAWLIS V BRYAN | Director | 2023-05-11 | SELL | 35,000 | $3 | $105K |
| Molineaux Susan | Director | 2023-05-01 | SELL | 35,000 | $2.48 | $86.8K |
| SCARLETT JOHN A | Chairman, President and CEO | 2023-02-10 | SELL | 1,340,000 | $3.04 | $4073.6K |
| GRETHLEIN ANDREW J | EVP, COO | 2023-02-09 | SELL | 384,719 | $3.03 | $1165.7K |
| Bloom Olivia Kyusuk | EVP, CFO | 2023-02-08 | SELL | 400,000 | $3.08 | $1232K |
| O'Farrell Elizabeth G. | Director | 2020-08-21 | BUY | 17,441 | $1.73 | $30.2K |
| O'Farrell Elizabeth G. | Director | 2020-01-10 | BUY | 3,000 | $1.34 | $4K |
| BEHRS MELISSA KELLY | EVP, Chief Business Officer | 2019-04-09 | SELL | 120,635 | $2 | $241.3K |
| Spiegel Robert J. | Director | 2018-09-13 | SELL | 175,000 | $6.85 | $1198.8K |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | 2018-08-24 | SELL | 1,362,250 | $4.51 | $6143.7K |
| Bloom Olivia Kyusuk | EVP, CFO | 2015-05-29 | SELL | 2,380 | $3.84 | $9.1K |
| BEHRS MELISSA KELLY | EVP BD and Port&Alliance Mgmt | 2015-05-29 | SELL | 2,380 | $3.84 | $9.1K |
| Hofstaetter Thomas | Director | 2015-03-18 | SELL | 70,000 | $4.1 | $287K |
| Bloom Olivia Kyusuk | EVP, CFO | 2014-05-29 | SELL | 3,379 | $2.1 | $7.1K |
| BEHRS MELISSA KELLY | EVP Portfolio & Alliance Mgmt | 2014-05-29 | SELL | 4,826 | $2.1 | $10.1K |
| BRADBURY DANIEL | Director | 2014-05-09 | BUY | 142,776 | $1.75 | $249.9K |
| BEHRS MELISSA KELLY | EVP Portfolio & Alliance Mgmt | 2014-04-01 | SELL | 12,310 | $2.13 | $26.2K |
| Bloom Olivia Kyusuk | EVP, CFO | 2014-04-01 | SELL | 7,435 | $2.13 | $15.8K |
| SCARLETT JOHN A | President and CEO | 2013-04-01 | BUY | 50,000 | $1.03 | $51.5K |
| BEHRS MELISSA KELLY | SVP Alliance and Prog Mgmt | 2013-01-17 | SELL | 28,292 | $1.65 | $46.7K |
| Kelsey Stephen Michael | EVP, R&D Head, CMO | 2012-05-30 | SELL | 9,300 | $1.37 | $12.7K |
| EARP DAVID | SVP, Corp Transactions | 2012-05-30 | SELL | 27,155 | $1.37 | $37.2K |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | 2012-05-30 | SELL | 11,029 | $1.37 | $15.1K |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | 2012-05-30 | SELL | 18,910 | $1.37 | $25.9K |
| KILEY THOMAS | Director | 2011-11-22 | BUY | 64,275 | $1.56 | $100.3K |
| EARP DAVID | Chief Legal Counsel | 2011-06-14 | SELL | 25,262 | $4.28 | $108.1K |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | 2011-06-14 | SELL | 6,997 | $4.28 | $29.9K |
| Spink Katharine E. | SVP Alliance Mgmt & Operations | 2011-06-14 | SELL | 22,591 | $4.28 | $96.7K |
| LEBKOWSKI JANE | SVP, Chief Scientific Officer | 2011-06-14 | SELL | 25,262 | $4.28 | $108.1K |
| Kelsey Stephen Michael | EVP, R&D Head, CMO | 2011-06-14 | SELL | 4,858 | $4.28 | $20.8K |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | 2011-06-14 | SELL | 25,262 | $4.28 | $108.1K |
| GREENWOOD DAVID | President, Interim CEO, CFO | 2011-06-14 | SELL | 34,005 | $4.28 | $145.5K |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | 2011-05-24 | SELL | 1,200 | $4.47 | $5.4K |
| Spink Katharine E. | SVP Prgm Mgmt, Cell Therapies | 2011-05-24 | SELL | 419 | $4.47 | $1.9K |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | 2011-05-24 | SELL | 2,975 | $4.47 | $13.3K |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2011-05-24 | SELL | 2,975 | $4.47 | $13.3K |
| LEBKOWSKI JANE | SVP, Chief Scientific Officer | 2011-05-24 | SELL | 2,975 | $4.47 | $13.3K |
| GREENWOOD DAVID | President, Interim CEO, CFO | 2011-05-24 | SELL | 4,462 | $4.47 | $19.9K |
| Kelsey Stephen Michael | EVP, CMO, Oncology | 2011-05-05 | SELL | 14,163 | $4.83 | $68.4K |
| Spink Katharine E. | VP Operations, Regen Med Progs | 2010-06-02 | SELL | 8,186 | $5.43 | $44.4K |
| LEBKOWSKI JANE | SVP, CSO Regen Med | 2010-06-02 | SELL | 10,617 | $5.43 | $57.7K |
| BEHRS MELISSA KELLY | SVP Oncology | 2010-06-02 | SELL | 10,617 | $5.43 | $57.7K |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2010-06-02 | SELL | 10,617 | $5.43 | $57.7K |
| GREENWOOD DAVID | EVP and CFO | 2010-06-02 | SELL | 14,746 | $5.43 | $80.1K |
| OKARMA THOMAS | President and CEO | 2010-06-02 | SELL | 18,874 | $5.43 | $102.5K |
| Spink Katharine E. | VP Operations, Regen Med Progs | 2010-05-24 | SELL | 385 | $5.11 | $2K |
| LEBKOWSKI JANE | SVP, CSO Regen Med | 2010-05-24 | SELL | 2,336 | $5.11 | $11.9K |
| BEHRS MELISSA KELLY | SVP Oncology | 2010-05-24 | SELL | 2,336 | $5.11 | $11.9K |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2010-05-24 | SELL | 2,336 | $5.11 | $11.9K |
| GREENWOOD DAVID | EVP and CFO | 2010-05-24 | SELL | 3,503 | $5.11 | $17.9K |
| OKARMA THOMAS | President and CEO | 2010-05-24 | SELL | 4,671 | $5.11 | $23.9K |
| Kelsey Stephen Michael | EVP, CMO, Oncology | 2010-04-28 | SELL | 3,707 | $5.66 | $21K |
| Spink Katharine E. | VP Operations, Regen Med Progs | 2009-05-29 | SELL | 400 | $6.35 | $2.5K |
| OKARMA THOMAS | President and CEO | 2009-05-29 | SELL | 5,828 | $6.35 | $37K |
| LEBKOWSKI JANE | SVP, CSO Regen Med | 2009-05-29 | SELL | 2,277 | $6.35 | $14.5K |
| BEHRS MELISSA KELLY | SVP Oncology | 2009-05-29 | SELL | 2,277 | $6.35 | $14.5K |
| HARLEY CALVIN | VP, CSO Telomerase Tech | 2009-05-29 | SELL | 2,277 | $6.35 | $14.5K |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2009-05-29 | SELL | 2,277 | $6.35 | $14.5K |
| GREENWOOD DAVID | EVP and CFO | 2009-05-29 | SELL | 3,416 | $6.35 | $21.7K |
| Benedetti Fabio M | SVP, Chief Med Off, Oncology | 2009-05-29 | SELL | 2,277 | $6.35 | $14.5K |
| Spink Katharine E. | VP Operations, Regen Med Progs | 2009-05-26 | SELL | 2,864 | $6.75 | $19.3K |
| OKARMA THOMAS | President and CEO | 2009-05-26 | SELL | 46,669 | $6.75 | $315K |
| BEHRS MELISSA KELLY | SVP Oncology | 2009-05-26 | SELL | 6,819 | $6.75 | $46K |
| LEBKOWSKI JANE | SVP, CSO Regen Med | 2009-05-26 | SELL | 14,092 | $6.75 | $95.1K |
| HARLEY CALVIN | VP, CSO Telomerase Tech | 2009-05-26 | SELL | 10,001 | $6.75 | $67.5K |
| GREENWOOD DAVID | EVP and CFO | 2009-05-26 | SELL | 19,320 | $6.75 | $130.4K |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2009-05-26 | SELL | 15,456 | $6.75 | $104.3K |
| Benedetti Fabio M | SVP, Chief Med Off, Oncology | 2009-04-03 | SELL | 5,195 | $4.44 | $23.1K |
| BEHRS MELISSA KELLY | SVP Oncology | 2009-02-02 | SELL | 14,765 | $8.12 | $119.9K |
| WALKER JOHN PETER | Director | 2009-01-30 | SELL | 48,617 | $8.28 | $402.5K |
| HARLEY CALVIN | VP and CSO | 2009-01-29 | SELL | 30,489 | $7.09 | $216.2K |
| OKARMA THOMAS | President and CEO | 2009-01-05 | SELL | 12,512 | $4.9 | $61.3K |
| LEBKOWSKI JANE | SVP Regen Medicine | 2009-01-05 | SELL | 8,861 | $4.9 | $43.4K |
| BEHRS MELISSA KELLY | SVP Oncology | 2009-01-05 | SELL | 8,861 | $4.9 | $43.4K |
| HARLEY CALVIN | VP and CSO | 2009-01-05 | SELL | 8,861 | $4.9 | $43.4K |
| GREENWOOD DAVID | EVP and CFO | 2009-01-05 | SELL | 10,732 | $4.9 | $52.6K |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2009-01-05 | SELL | 8,861 | $4.9 | $43.4K |
| BEHRS MELISSA KELLY | SVP Oncology | 2008-11-05 | SELL | 23,845 | $4.05 | $96.6K |
| OKARMA THOMAS | President and CEO | 2008-01-04 | SELL | 13,166 | $5.34 | $70.3K |
| LEBKOWSKI JANE | SVP Regen Medicine | 2008-01-04 | SELL | 8,911 | $5.34 | $47.6K |
| BEHRS MELISSA KELLY | SVP Oncology | 2008-01-04 | SELL | 8,911 | $5.34 | $47.6K |
| HARLEY CALVIN | VP and CSO | 2008-01-04 | SELL | 8,911 | $5.34 | $47.6K |
| GREENWOOD DAVID | EVP and CFO | 2008-01-04 | SELL | 11,039 | $5.34 | $58.9K |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 2008-01-04 | SELL | 8,911 | $5.34 | $47.6K |
| GREENWOOD DAVID | EVP and CFO | 2007-11-12 | SELL | 4,000 | $7.2 | $28.8K |
| HARLEY CALVIN | VP and CSO | 2007-05-18 | SELL | 30,000 | $9.19 | $275.7K |
| BEHRS MELISSA KELLY | VP, Oncology | 2006-01-09 | SELL | 8,441 | $8.56 | $72.3K |
| LEBKOWSKI JANE | SVP, Regenerative Medicine | 2006-01-09 | SELL | 10,676 | $8.56 | $91.4K |
| OKARMA THOMAS | President and CEO | 2006-01-09 | SELL | 12,320 | $8.56 | $105.5K |
| HARLEY CALVIN | Chief Scientific Officer | 2006-01-09 | SELL | 9,183 | $8.56 | $78.6K |
| GREENWOOD DAVID | Executive VP and CFO | 2006-01-09 | SELL | 12,183 | $8.56 | $104.3K |
| EARP DAVID | SVP Bus Dev / Chf Patent Couns | 2006-01-09 | SELL | 11,323 | $8.56 | $96.9K |
| KELLY MELISSA | VP, Oncology | 2005-07-29 | SELL | 65,571 | $10.88 | $713.4K |
| GREENWOOD DAVID | Executive VP and CFO | 2005-07-20 | SELL | 30,000 | $10.45 | $313.5K |
| HARLEY CALVIN | Chief Scientific Officer | 2005-07-20 | SELL | 25,000 | $10.46 | $261.5K |
| HARLEY CALVIN | Chief Scientific Officer | 2005-01-13 | SELL | 9,929 | $8.57 | $85.1K |
| OKARMA THOMAS | President and CEO | 2005-01-13 | SELL | 14,283 | $8.57 | $122.4K |
| KELLY MELISSA | VP, Oncology | 2005-01-13 | SELL | 8,648 | $8.57 | $74.1K |
| LEBKOWSKI JANE | SVP, Regenerative Medicine | 2005-01-13 | SELL | 6,154 | $8.57 | $52.7K |
| GREENWOOD DAVID | Executive VP, CFO | 2005-01-13 | SELL | 13,804 | $8.57 | $118.3K |
| EARP DAVID | SVP Bus Dev / Chf Patent Couns | 2005-01-13 | SELL | 9,239 | $8.57 | $79.2K |
| MERIX BIOSCIENCE INC | 10% Owner | 2004-08-16 | SELL | 65,500 | $5.57 | $364.8K |
| MERIX BIOSCIENCE INC | 10% Owner | 2004-08-13 | SELL | 47,000 | $5.52 | $259.4K |
| MERIX BIOSCIENCE INC | 10% Owner | 2004-08-12 | SELL | 167,900 | $5.95 | $999K |
| MERIX BIOSCIENCE INC | 10% Owner | 2004-08-11 | SELL | 42,000 | $5.46 | $229.3K |
| MERIX BIOSCIENCE INC | 10% Owner | 2004-08-10 | SELL | 101,500 | $5.28 | $535.9K |
| MERIX BIOSCIENCE INC | 10% Owner | 2004-08-06 | SELL | 35,000 | $5.52 | $193.2K |
| KELLY MELISSA | VP, Oncology | 2004-04-06 | SELL | 2,029 | $9.6 | $19.5K |
| GREENWOOD DAVID | Sr. VP, Corp Dev and CFO | 2004-04-06 | SELL | 6,000 | $9.51 | $57.1K |
| HARLEY CALVIN | Chief Scientific Officer | 2004-04-01 | SELL | 6,321 | $9.23 | $58.3K |
| STEIN ROBERT B | Director | 2003-12-01 | SELL | 20,625 | $12.42 | $256.2K |
| STEIN ROBERT B | Director | 2003-09-23 | SELL | 15,050 | $12.5 | $188.1K |
| STEIN ROBERT B | Director | 2003-09-10 | SELL | 23,400 | $8.78 | $205.5K |
| GREENWOOD DAVID | Sr. VP, Corp Dev and CFO | 2003-07-31 | SELL | 16,011 | $8.24 | $131.9K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked